A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

ClinicalTrials.gov ID: NCT06390410

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06390410. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate simufilam levels in the blood of hepatically impaired individuals compared to Healthy individuals of similar demographics

Study identification

NCT ID: NCT06390410
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Cassava Sciences, Inc.; Industry
Enrollment: 27 participants

Conditions and interventions

Conditions

Hepatic Insufficiency

Interventions

Simufilam Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 26, 2024 (Actual)
Primary completion: Dec 7, 2024 (Actual)
Completion: Dec 7, 2024 (Actual)
Last update posted: Jan 7, 2025

2024

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 3

Facility	City	State	ZIP	Site status
Orange County Research Center	Lake Forest	California	92630	—
Clinical Pharmacology of Miami	Miami	Florida	33014	—
Orlando Clinical Research Center	Orlando	Florida	32809	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06390410, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 7, 2025 · Synced Nov 12, 2026